DCT and neoplasm: The weak triggering of a TRP2180–188-specific immune response in the CN OMVs and SnT-TRP2 + CN OMVs groups could be due to the release of TRP2 antigen from tumor cells killed by the OMV-activated innate immune system and the mixed SnT-TRP2, respectively.